Ozempic is part of a group of drugs called glucagon-like peptide-1 receptor agonists (GLP-1s) and contains the active ingredient semaglutide
This review, focusing on its therapeutic efficacy and tolerability, delves into pivotal trials such as REWIND CVOT, elucidating its pharmacological profile and clinical utility in T2D management
Are they worthy of all the hype? History is littered with failed weight-loss wonder drugs
You should not consider Semaglutide if you: are currently pregnant or breastfeeding have Medullary thyroid cancer or family history of Medullary thyroid cancer have severe kidney disease have a history of pancreatitis, gallstones, or similar medical conditions have a history of inflammatory bowel disease or other gastrointestinal disorders Potential side effects of Semaglutide While semaglutide is a safe and effective treatment of obesity and weight management, there are potential side effects, as with all medication
These pathways are involved in appetite, fullness, digestion, glucose regulation, and energy balance